His primary areas of investigation include Molecular biology, Immunology, Adenocarcinoma, Gene expression profiling and Proteome. His Immunology study integrates concerns from other disciplines, such as Hematopoietic stem cell transplantation and Graft-versus-host disease. His Adenocarcinoma research integrates issues from Cancer research, Lung cancer, Serous fluid, Pathology and Lung.
His Pathology study combines topics in areas such as Ovarian carcinoma and Cancer, Pancreatic cancer. His studies deal with areas such as Oncology and Early detection as well as Cancer. The concepts of his Proteome study are interwoven with issues in Cell, Proteomics, Computational biology and Mass spectrometry.
Samir M. Hanash mostly deals with Cancer, Cancer research, Molecular biology, Proteomics and Internal medicine. His work deals with themes such as Lung cancer, Pathology and Immune system, Immunology, which intersect with Cancer. His Cancer research study also includes fields such as
His Molecular biology research focuses on DNA methylation and how it relates to Methylation. His research integrates issues of Blood proteins, Proteome, Bioinformatics and Computational biology in his study of Proteomics. His Internal medicine research incorporates elements of Gastroenterology and Oncology.
His primary areas of investigation include Cancer research, Cancer, Internal medicine, Phenotype and Immune system. His Cancer research research includes elements of Cell, Carcinogenesis, Cancer cell, Proteomics and Adenocarcinoma. In his study, Microvesicles is strongly linked to Liquid biopsy, which falls under the umbrella field of Proteomics.
His Cancer study combines topics from a wide range of disciplines, such as Autoantibody and Genome. Samir M. Hanash interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine. Samir M. Hanash has researched Immune system in several fields, including Antibody and Antigen.
Samir M. Hanash mainly investigates Cancer research, Lung cancer, Immune system, Phenotype and Cancer. His Cancer research research is multidisciplinary, incorporating elements of Cancer cell, Autoantibody, Carcinogenesis, STAT3 and Adenocarcinoma. His research in Adenocarcinoma tackles topics such as Microbiome which are related to areas like Disease.
His Lung cancer study is concerned with the larger field of Internal medicine. The study incorporates disciplines such as Gastroenterology and Stomach in addition to Cancer. His Molecular biology study combines topics in areas such as Biomarker, Liquid biopsy and Proteomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene-expression profiles predict survival of patients with lung adenocarcinoma
David G. Beer;Sharon L.R. Kardia;Chiang Ching Huang;Thomas J. Giordano.
Nature Medicine (2002)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen;Lu Li;Yuxuan Wang;Christopher Thoburn.
Mining the plasma proteome for cancer biomarkers
Samir M. Hanash;Sharon J. Pitteri;Vitor M. Faca.
Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis.
Bruce C. Richardson;Lee Scheinbart;John R. Strahler;Laura Gross.
Arthritis & Rheumatism (1990)
Molecular Profiling of Pancreatic Adenocarcinoma and Chronic Pancreatitis Identifies Multiple Genes Differentially Regulated in Pancreatic Cancer
Craig D. Logsdon;Diane M. Simeone;Charles Binkley;Thiruvengadam Arumugam.
Cancer Research (2003)
Mining gene expression databases for association rules
Chad Creighton;Samir Hanash.
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
E Cornacchia;J Golbus;J Maybaum;J Strahler.
Journal of Immunology (1988)
Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function
Bong Kyung Shin;Hong Wang;Anne Marie Yim;Francois Le Naour.
Journal of Biological Chemistry (2003)
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
Donald R. Schwartz;Sharon L R Kardia;Kerby A. Shedden;Rork Kuick.
Cancer Research (2002)
Proteomic Analysis of Lung Adenocarcinoma: Identification of a Highly Expressed Set of Proteins in Tumors
Guoan Chen;Tarek G. Gharib;Chiang Ching Huang;Dafydd G. Thomas.
Clinical Cancer Research (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: